Abstract
The co-existence of mutations in the BRCA1 and BRCA2 genes is unusual, and to date almost all cases reported have had at least one of the Ashkenazi founder mutations. We report on a family in whom individuals are double heterozygotes for a mutation in BRCA1 and a novel splice site mutation in BRCA2. The phenotypes are discordant, where one sister has had multiple cancers in the BRCA spectrum, while the other is unaffected at 65 years of age. The utility of testing is discussed, and the completion of diagnostic testing despite the finding of a potentially causal mutation is validated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Lui Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, ToninP, Narod S, Bristow Pk, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright I, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian susceptibility gene BRCA1. Science 266:66–71
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet 343:692–695
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088–2090
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Stratton M (1995) Identification of the breast susceptibility gene BRCA2. Nature 378:789–792
The Breast Cancer Linkage Consortium (1999) Cancer Risks in BRCA2 mutaion carriers. J Natl Cancer Inst 91:1310–1316
Welcsh PL, King MC (2001) BRCA1 and BRCA2 in the genetics of breast and ovarian cancer. Hum Mol Genet 10(7):705–713
Hopper JL, Southey MC, Dite GS, Jolley DL, Giles GG, McCredie MR, Easton DF, Venter DJ (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741–747
Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490
Schubert EL, Metford HC, Dann JL, Argonza RH, Hull J, King MC (1997) BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genet Test 1(1):41–46
Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Idenden R, Woodward ER, Lalloo F, Maher ER, Evans DGR (2006) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 0:1–6
Leegte B, Van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, Berge A, Leenders EP, Wesseling J, De Hullu J, Hoogerbrugge N, Ligtenberg MJL, Ardern-Jones A, Bancroft E, Salmon E, Barwell J, Eeles R, Oosterwijk JC (2005) Phenotypic expression of double heterzygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42(3):e20
Choi DH, Lee MH, Haffty BG (2006) Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes. Breast J 12(3):216–220
James PA, Doherty R, Harris M, Mukesh B, Milner A, Young M-A, Scott C (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. JCO 24(4):707–715
Breast cancer information core (BIC) database: http://research.nhgri.nih.gov/bic/
Antoniou A, Pharoah P, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130
Niell B, Rennert G, Bonner J et al (2004) BRCA 1 and 2 founder mutations and the risk of colorectal cancer. JNCI 96(1):15–21
Acknowledgements
The Familial Cancer Clinic is supported by the Department of Human Services, VIC, Australia. Thanks to Maureen Ralph for administrative support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, M., Fawcett, S., Sigalas, E. et al. Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes. Familial Cancer 7, 119–124 (2008). https://doi.org/10.1007/s10689-007-9154-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-007-9154-8